EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,252 | -60.2% | 159,780 | -13.9% | 0.00% | -66.7% |
| Q2 2023 | $1,363,896 | +1012.7% | 185,564 | +1468.3% | 0.00% | – |
| Q1 2023 | $122,579 | -99.1% | 11,832 | -97.4% | 0.00% | -100.0% |
| Q2 2022 | $13,922,000 | +1459.0% | 448,533 | +2085.9% | 0.03% | +1350.0% |
| Q4 2021 | $893,000 | -85.5% | 20,519 | -83.3% | 0.00% | -92.3% |
| Q3 2021 | $6,145,000 | -12.5% | 122,719 | +10.1% | 0.03% | -18.8% |
| Q2 2021 | $7,019,000 | -20.7% | 111,423 | -32.0% | 0.03% | -47.5% |
| Q4 2019 | $8,846,000 | -42.5% | 163,975 | -44.3% | 0.06% | -49.6% |
| Q3 2019 | $15,383,000 | +322.8% | 294,242 | +290.7% | 0.12% | +303.3% |
| Q2 2019 | $3,638,000 | +560.3% | 75,306 | +350.2% | 0.03% | +328.6% |
| Q2 2015 | $551,000 | -21.6% | 16,729 | -49.3% | 0.01% | -30.0% |
| Q3 2014 | $703,000 | -78.1% | 33,002 | -76.9% | 0.01% | -78.7% |
| Q2 2014 | $3,204,000 | – | 142,650 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |